RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
Cougar Biotechnology Inc: Premium Company Profile
Apr 2008 - 39 pages - $495
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
Feb 2011 - 17 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
Sonus Pharmaceuticals Inc: Premium Company Profile
Jan 2008 - 41 pages - $495
Premium Company Profile Achillion Pharmaceuticals
Nov 2007 - 44 pages - $495
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Oncology del
Treatments del
Year
2002 del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Manufacturing
Nanotechnology
Other
Research supplies
Stem cells
Therapeutic target
Anti-angiogenesis
Cancer Antibodies
Chemotherapy
Radioimmunotherapy
Radiotherapy
Vaccines

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us